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Exome Sequencing Identifies
PDE4D Mutations in Acrodysostosis
Hane Lee,1,2 John M. Graham, Jr.,3,9 David L. Rimoin,1,3,4,9 Ralph S. Lachman,5,9 Pavel Krejci,9,10
Stuart W. Tompson,8 Stanley F. Nelson,1,2 Deborah Krakow,1,6,7 and Daniel H. Cohn7,8,*
Acrodysostosis is a dominantly-inherited, multisystem disorder characterized by skeletal, endocrine, and neurological abnormalities. To
identify the molecular basis of acrodysostosis, we performed exome sequencing on five genetically independent cases. Three different
missense mutations in PDE4D, which encodes cyclic AMP (cAMP)-specific phosphodiesterase 4D, were found to be heterozygous in
three of the cases. Two of the mutations were demonstrated to have occurred de novo, providing strong genetic evidence of causation.
Two additional cases were heterozygous for de novo missense mutations in PRKAR1A, which encodes the cAMP-dependent regulatory
subunit of protein kinase A and which has been recently reported to be the cause of a form of acrodysostosis resistant to multiple
hormones. These findings demonstrate that acrodysostosis is genetically heterogeneous and underscore the exquisite sensitivity of
many tissues to alterations in cAMP homeostasis.Acrodysostosis (MIM 101800), also known as Arkless-
Graham syndrome or Maroteaux-Malamut syndrome, is
a pleiotropic disorder characterized by skeletal, endocrine,
and neurological abnormalities.1,2 Skeletal features include
brachycephaly, midface hypoplasia with a small upturned
nose, brachydactyly, and lumbar spinal stenosis. Endo-
crine abnormalities have been reported and include hypo-
thyroidism and hypogonadism in males and irregular
menses in females (summarized in Butler et al.). Develop-
mental disability is a common finding but is variable in
severity and can be associated with significant behavioral
problems. Most cases are sporadic, and there is evidence
of a paternal age effect,3 suggesting that the phenotype
might result from de novo point mutations. Perhaps as
a result of the developmental disability and/or endocrine
abnormalities, there are only a few examples of dominant
transmission.4,5 Recently, dominant mutations in
PRKAR1A (MIM 188830), which encodes the cyclic AMP
(cAMP)-dependent regulatory subunit of protein kinase A
(PKA), were found in a subset of acrodysostosis cases
resistant to multiple hormones.6 The mutations resulted
in reduced PKA activation by cAMP and led to a reduced
hormone response in multiple tissues.
We studied five sporadic cases, four males and one
female, who had clinical and radiographic phenotypes
(Figure 1, Table 1) consistent with the diagnosis of acrody-
sostosis. A prior publication7 contains additional clinical
details on three of the five cases (International Skeletal
Dysplasia Registry reference numbers R99-101A [case 1 in
Graham et al.7], R99-514A [case 2], and 95-141A [case
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board at Cedars-Sinai Medical Center. To determine the
molecular basis of the phenotype in each case, we per-
formed exome capture and sequence analysis. In three
cases (R02-309A, R06-434A, and R95-141A), DNA from
the unaffected parents was also available at the outset
of the study, and we determined the exome sequences for
the six parents to facilitate the identification of de novo
mutations in these trios. High-molecular-weight genomic
DNA was extracted from either blood or lymphoblastoid
cell lines; the quality of the DNA samples was determined
by a Qubit Fluorometer (Invitrogen) and a Bioanalyzer
(Agilent). For each sample, we prepared the sequencing
library with 3 mg of genomic DNA and used the Agilent
SureSelect Target Enrichment System to construct an
Illumina Paired-End Sequencing library (protocol version
2.0.1). The Agilent SureSelect Human All Exon 50Mb kit
was used for the exome capture. Sequences for each sample
(50 bp paired end) were determined on a single lane of an
Illumina HiSeq2000 instrument, and a total of 82–123
million paired-end reads per sample were generated. We
performed base-calling by using the real-time analysis
(RTA) software provided by Illumina.
We aligned the sequence reads to human reference
genome human_g1k_v37.fasta (downloaded from the
Genome Analysis Toolkit [GATK] resource bundle in
November 2010) by using Novoalign from the Novocraft
Short Read Alignment Package; the adaptor-stripping
and base-quality-calibration options were on. We used
SAMtools version 0.1.15 to sort the aligned BAM files,
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Figure 1. Radiographic Phenotype in Acrodysostosis Cases
For four of the cases, anteroposterior hand (A–D), lateral-skull (E–H), and lumbar-spine (I–L) radiographs are shown. Individuals R02-309
and R99-101 have mutations in PRKAR1A, and individuals R06-434 and R95-141 have mutations in PDE4D. Arrows on the lateral-skull
films identify midface hypoplasia. Arrows on the lumbar-spine films indicate absence of normal interpedicular widening in the lumbar
vertebrae; the absence of such widening predisposes the affected individuals to spinal stenosis. The case numbers are indicated across
the top.using Picard. On average, 88.2% of the reads were uniquely
aligned to the reference genome. The PCR duplication rate
varied between 5.1% and 8.2%, and there was an average
estimated library size of 704 million unique fragments.
The on-target rate, or capture specificity, varied from 60%
to 63.8%. The mean coverage across the captured regions
was 973, and approximately 92% of the targeted bases
were covered by R10 reads for each exome.
We performed local realignment for each sample by
using the GATK ‘‘IndelRealigner’’ tool, and we recalibrated
base qualities by using the GATK ‘‘TableRecalibration’’ tool
according to GATK’s recommendation (Best Practice
Variant Detection with the GATK version 2). Variants
were simultaneously called with the GATK ‘‘Unified
Genotyper’’ tool for all 11 samples (the five cases and six
unaffected parents). Small indels were called with the
‘‘-glm DINDEL’’ option. The dbSNP132 file downloaded
from the GATK resource bundle was used so that the
known SNP positions were annotated in the output
VCF (variant call format) file. Only the variants found
within the protein coding regions of the captured exons
were reported with the –L option. The interval file that
we used is available upon request. Using the GATKThe Am‘‘VariantFiltrationWalker’’ tool, we hard filtered both the
SNPs and INDELs to remove low-quality variants. As sug-
gested by GATK, we used the following parameters for
standard filtration: (1) the clusterWindowSize was 10, (2)
mapping quality of zero was >40, (3) quality by depth
was <5.0, and (4) strand bias was >0.10.
We annotated the ‘‘PASS’’-ed variants that were not
found at dbSNP132 positions by using SeattleSeqAnnota-
tion version 6.16 (SNPs and INDELs were annotated sepa-
rately). Both NCBI (National Center for Biotechnology
Information) full genes and CCDS (consensus coding
sequence) 2010 gene models were used for the annotation.
Variants present in the 1,000 Genomes Database (March
2010 release) or dbSNP131 as well as those resulting in
synonymous coding changes or found outside the coding
region were removed from further analysis.
The annotated variants were first examined in the trios
and were further filtered under a rare dominant model.
Because acrodysostosis is dominantly inherited and was
sporadic in the cases studied, we prioritized the variants
to examine the de novo variants. We identified potential
de novo variants by selecting the heterozygous variants
found only in the case but not in the parents, and weerican Journal of Human Genetics 90, 746–751, April 6, 2012 747
Table 1. Clinical Findings in the Five Cases of Acrodysostosis
R06-434A R95-141A R99-514 R02-309A R99-101A
Sex female male male male male
Locus PDE4D PDE4D PDE4D PRKAR1A PRKAR1A
Skeletal abnormalities
Short stature no mild mild mild mild
Small hands yes yes yes yes yes
Midface hypoplasia yes yes yes yes yes
Lumbar stenosis unknown yes yes yes yes
Neurological abnormality
Developmental disability no significant mild mild mild
Endocrine abnormalities
Hypothyroidism no no congenital no congenital
Hypogonadism unknown cryptorchidism no no unilateral undescended
testis
Hearing loss no no no no moderate mixedmanually inspected the raw reads of these variants to verify
that each was absent from the parental sequences.
Individual R06-434A had two de novo variants, and both
were of good quality (Table 2). Individual R95-141A
also had two potential de novo variants, but one variant
was found in a poor coverage region, and there was insuf-
ficient coverage in the parental samples for this variant
to be reliably called. Two de novo variants (c.682C>G
[p.Gln228Glu] in R06-434A and c.1769A>C [p.Glu590Ala]
in R95-141A) found in these first two individuals were
located in the same gene, PDE4D (RefSeq accession
number NM_001104631.1; MIM 600129), and an addi-
tional PDE4D variant (c. 2018G>A [p.Gly673Asp]) was
identified in a third individual, R99-514. All PDE4D vari-
ants were confirmed by Sanger-sequence analysis of PCR-
amplified fragments, and the unaffected parents wereTable 2. De Novo Variants Identified by Exome Sequencing in the Five
Individual Chromosome
Genomic
Position
Reference
Sequence
Variant
Sequence Locus
R06-434A 5 58,489,328 G/G G/C PDE4D
R06-434A 7 148,963,588 C/C C/T ZNF783
R95-141A 5 58,272,238 T/T T/G PDE4D
R99-514 5 58,270,903 C/C C/T PDE4D
R02-309A 17 66,526,448 G/G G/C PRKAR1
R02-309A 2 175,264,813 T/T T/C SCRN3
R99-101 17 66,526,424 T/T T/C PRKAR1
748 The American Journal of Human Genetics 90, 746–751, April 6, 2shown to not carry the changes identified in their
offspring. In the third individual (R99-514), the PDE4D
variant was not found in DNA from the mother, and the
father could not be studied because he is deceased. These
data provide strong genetic evidence that the PDE4D
mutations are causative.
Individual R02-309A had three potential de novo vari-
ants. However, one variant showed evidence that the
same nonreference allele was present in one of the parents
even though it was not called as a variant, leaving two
potential de novo variants in this individual (Table 2).
Both variants were confirmed by Sanger-sequence analysis
of PCR-amplified fragments containing the changes.
One of the de novo variants (c.1004G>C [p.Arg335Pro])
was located in PRKAR1A (RefSeq accession number
NM_002734.3), the gene previously associated withCases of Acrodysostosis
cDNA
Position
Protein
Change De Novo?
Polyphen-2
Prediction
SIFT
Prediction
c.682C>G p.Gln228Glu yes probably
damaging
damaging
c.187C>T p.Arg63Cys yes  damaging
c.1769A>C p.Glu590Ala yes probably
damaging
damaging
c.2018G>A p.Gly673Asp not in
mother
probably
damaging
damaging
A c.1004G>C p.Arg335Pro yes probably
damaging
damaging
c.302T>C p.Leu108Ser yes probably
damaging
tolerated
A c.980T>C p.Ile327Thr yes probably
damaging
damaging
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Figure 2. cAMP Signaling Cascade
Ligand binding (represented in this example by PTH, but other ligands and receptors can stimulate cAMP synthesis), activates Gs-a and
stimulates cAMP synthesis by adenylate cyclase. The binding of cAMP by PRKAR1A, the cAMP-dependent regulatory subunit, leads to
the dissociation and activation of PKA and the subsequent phosphorylation of cAMP response element binding (CREB), nuclear trans-
location, and expression of downstream genes. PDE4D phosphodiesterase activitymodulates cAMP levels.Mutations (indicated by aster-
isks) in the genes encoding these three components of the pathway result in a spectrum of clinically related disorders— acrodysostosis
for mutations in PDE4D or PRKAR1A or Albright hereditary osteodystrophy for mutations in GNAS, the gene encoding Gs-a.acrodysostosis with hormone resistance.6 Individual R99-
101 was also found to have a variant (c.980T>C
[p.Ile327Thr]) in PRKAR1A, and subsequent Sanger-
sequence analysis of a PCR-amplified fragment confirmed
the mutation and demonstrated its absence from DNA
derived from the parents; this analysis indicated that the
variant resulted from a de novo event. Therefore, acrody-
sostosis in these latter two individuals appears to have re-
sulted from PRKAR1A mutations.
All five missense variants (three in PDE4D and two in
PRKAR1A) were predicted to be damaging by PolyPhen-2
(Polymorphism Phenotyping version 2) and/or SIFT, two
commonly used tools that predict the functional conse-
quences of amino acid changes on the basis of sequence
homology and the physical properties of the amino acids.
None of these variants were observed in an internal exome
dataset of 48 individuals affected by different medical
conditions, in a group of 250 published exome data-
sets,8,9 or among the 5,379 exomes available from the
National Heart, Lung, and Blood Institute (NHLBI) Exome
Sequencing Project Exome Variant Server (ESP5400).
The findings described here thus demonstrate that acro-
dysostosis can result from missense mutations in PDE4D,
the gene encoding cAMP-dependent phosphodiesterase
4D. PDE4D encodes at least five isoforms that differ at their
amino-terminal ends as a result of alternate transcription
start sites or alternative splicing.10 The encoded proteins
range in size from 508 to 810 amino acids, and the threeThe Amlonger isoforms contain two highly evolutionarily con-
served upstream regions (UCR1 and UCR2) and the large
catalytic domain. The two shorter isoforms lack the
amino-terminal UCR1 domain, which regulates catalytic
activity along with UCR2.11 The p.Gln228Glu substitution
alters a conserved residue in the UCR1 region, indicating
that disruption of the longer isoforms alone is enough to
cause a phenotypic effect in the target tissues and result
in acrodysostosis. The p.Glu590Ala and p.Gly673Asp sub-
stitutions alter conserved catalytic-domain amino acids,
indicating that these residues are essential for normal
PDE4D activity.
The results of this study also confirm that mutations in
PRKAR1A, which encodes the cyclic AMP-dependent regu-
latory subunit of PKA, can also lead to acrodysostosis.6 The
two substitutions, p.Arg335Pro and p.Ile327Thr, found in
PRKAR1A were different than the recurrent mutation
(p.R368*) previously reported,6 but all three mutations
were in exon 11, which encodes part of the highly
conserved cAMP-binding domain B. Binding of cAMP by
PRKAR1A is required for the release and activation of
PKA (Figure 2), which then phosphorylates and activates
CREB; this process then leads to the expression of down-
stream targets. This suggests that these mutations could
cause reduced cAMP binding and result in reduced PKA
activation and, consequently, reduced downstream signal-
ing. This mechanism would distinguish the acrodysostosis
mutations from the PRKAR1Amutations that cause Carneyerican Journal of Human Genetics 90, 746–751, April 6, 2012 749
complex (the mutations that cause Carney complex
primarily lead to reduced PRKAR1A synthesis, lack of regu-
latory control of PKA activation, and derepression of
CREB-mediated targets).12
The clinical and radiographic phenotypes (summarized
in Table 1) facilitated comparing the acrodysostosis cases
with the typical symptoms associated with either PDE4D
or PRKAR1A mutations. Mild short stature with small
hands was present in all of the cases, including those
with PRKAR1Amutations previously described,6 regardless
of the locus involved. Similarly, stenosis of the lumbar
spine and midface hypoplasia with a small nose were
consistent findings both clinically and radiographically
(Figure 1). However, endocrine abnormalities were vari-
able; hypothyroidism was documented in just two of the
individuals, R99-514 (who had a PDE4D mutation) and
R99-101 (who had a PRKAR1Amutation). Hypothyroidism
persisted in individual R99-101 but spontaneously
resolved in individual R99-514 when he reached three
years of age. However, firm conclusions cannot be made
from these observations because the number of cases
studied thus far is too small. One of the four male individ-
uals with a PDE4D mutation (R95-141A) had cryptorchi-
dism. One of the PRKAR1A individuals described here,
R99-101, exhibited a unilateral undescended testis, and
both of the males previously described6 had cryptorchi-
dism, indicating that hypogonadism can be found in cases
with defects in either gene. From a neurological viewpoint,
four of the five individuals studied had some degree of
developmental disability, and one individual (R95-141A)
displayed significant behavioral problems. Thus, it is diffi-
cult to distinguish acrodysostosis cases with PDE4D muta-
tions from those with PRKAR1A mutations by clinical
observation only.
The acrodysostosis phenotype is similar to that of Pde4d-
knockout mice.13 As in humans with acrodysostosis,
Pde4d-nullmice exhibit reduced growth andmidface hypo-
plasia. Females with acrodysostosis have been reported to
have irregular menses, and knockout mice have reduced
fertility associated with decreased ovulation and oocyte
degeneration. These observations suggest that the human
mutations lead to reduced PDE4D activity. Because the
heterozygous knockout mice were phenotypically normal
and had essentially normal phosphodiesterase activity,13
it appears that haploinsufficiency for PDE4D activity has
no phenotypic consequence. Because PDE4D is a dimer,
the data suggest the possibility that the missense alleles
identified in the acrodysostosis cases might cause the
phenotype via a dominant-negative effect on the protein.
Albright hereditary osteodystrophy (MIM 103580)
shares phenotypic features, including short stature, bra-
chydactyly, hormone resistance, and varying degrees of
developmental disability, with acrodysostosis and results
frommutations in GNAS14 (MIM 139320), the gene encod-
ing the adenylate cyclase activating protein Gs-a. Gs-a,
PDE4D, and PRKAR1A are all components of the cAMP
signaling pathway (Figure 2). The disruption of PRKAR1A750 The American Journal of Human Genetics 90, 746–751, April 6, 2and GNAS causes downregulation of the cAMP signaling
cascade in response to an external signal, such as parathy-
roid hormone (PTH). Although decreased PDE4D activity
might be predicted to increase cAMP levels, it has been sug-
gested13 that inactivation of PDE4D-mediated negative
feedback would cause a permanent desensitization state
of the cAMP signaling pathway; this desensitization would
paradoxically lead to a significant reduction in the cAMP
response. Consequently, the phenotypic effects resulting
from PDE4Dmutations would be similar to those resulting
from PRKAR1A and GNAS defects.
PDE4D is orthologous to Drosophila dunce, which has
been shown to play a role in learning and memory in
flies.15 Flies deficient in dunce have reduced cAMP
phosphodiesterase activity,16 a reduction which results in
defects in both associative and nonassociative memory.17
Although increased branching of terminal neuronal
processes has been observed in dunce larvae (implicating
abnormal brain morphology as an element of the pheno-
type18), alterations that occur in the biochemical process
of memory as a result of altered cAMP levels in the
mushroom body of the Drosophila brain appear to be the
predominant effect of dunce mutations.19 Because most
acrodysostosis cases exhibit significant developmental
disabilities, the data presented here raise the possibility
that PDE4D deficiency disrupts a highly evolutionarily
conserved neurological pathway.
Thus, a variety of genetic defects that alter cAMP metab-
olism produce disorders with a related constellation of
findings, which include short stature with brachydactyly,
endocrine abnormalities, and developmental disability.
However, the precise role of PDE4D in the skeleton, partic-
ularly in growth-plate cartilage, is not well understood.
Loss of cAMP activity as a result of a chondrocyte-specific
knockout of Gs-a revealed severe growth-plate abnormali-
ties, accelerated hypertrophic chondrocyte differentiation
with ectopic cartilage formation, and increased parathy-
roid hormone-related peptide expression in periarticular
chondrocytes.20 Individuals with acrodysostosis have
been reported to exhibit accelerated bone maturation
as well as ectopic bone formation,21,22 supporting the
hypothesis that a component of the cartilage phenotype
might be reduced activity of the cAMP signaling cascade.
It remains to be determined whether modulation of cAMP
levels could ameliorate the phenotypic consequences of
mutations in the pathway in any meaningful way, espe-
cially in the primary target tissues of the skeleton, brain,
and endocrine organs. Understanding the complexity of
cAMP regulation among the affected tissues would be an
important step in achieving this goal.Acknowledgments
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